---
schema_version: "secwatch.filing_event.v1"
accession: "0001798749-24-000055"
form_type: "8-K"
ticker: "JBIO"
cik: "0001798749"
company_name: "Jade Biosciences, Inc."
filed_at: "2024-10-17T23:59:59+00:00"
generated_at: "2026-05-30T13:24:34.291302+00:00"
event_type: "regulatory"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# Aerovate regains Nasdaq audit committee compliance by appointing Habib J. Dable

## Summary
- Company notified Nasdaq of noncompliance on Oct 11 due to only two audit committee members after Dr. Katabi's resignation.
- Board appointed director Habib J. Dable to the audit committee effective Oct 17, 2024.
- With Dable's appointment, Aerovate regained compliance with Nasdaq Listing Rule 5605(c)(2).

## SEC filing metadata
- accession: 0001798749-24-000055
- form_type: 8-K
- ticker: JBIO
- cik: 0001798749
- company_name: Jade Biosciences, Inc.
- filed_at: 2024-10-17T23:59:59+00:00
- event_type: regulatory
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 3.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1798749/000179874924000055/0001798749-24-000055-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1798749/000179874924000055/tmb-20241011x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001798749-24-000055
- JSON: https://secwatch.observer/filing/0001798749-24-000055.json
- Plain text: https://secwatch.observer/filing/0001798749-24-000055.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.